Yong Huang
About Yong Huang
Yong Huang is the Director at Bristol-Myers Squibb in Japan, with over 25 years of experience in the pharmaceutical industry, focusing on drug safety evaluation and pharmacovigilance.
Current Role at Bristol-Myers Squibb
Yong Huang currently serves as a Director at Bristol-Myers Squibb in Japan. With extensive experience in the pharmaceutical industry, he leads initiatives related to drug safety evaluation and pharmacovigilance. His role involves ensuring compliance with both Japanese and international regulatory requirements, contributing to the safety and efficacy of pharmaceutical products.
Previous Roles at IQVIA and Otsuka
Before joining Bristol-Myers Squibb, Yong Huang held significant roles at other major pharmaceutical companies. From 2013 to 2016, he was an Associate Director at IQVIA, focusing on drug safety. Prior to that, he spent nine years at Otsuka from 2004 to 2013 as a Director. His responsibilities included overseeing drug safety and regulatory compliance, enhancing his expertise in pharmacovigilance.
Academic Background and Postdoctoral Experience
Yong Huang has a robust academic background, having achieved a PhD from Yamagata University (1990-1994) and an MD from Fudan University (1981-1987). His early career includes postdoctoral positions at the University of Calgary (1998-2004) and the University of Florida (1995-1998). He also served as an Assistant Professor at Yamagata University from 1994 to 1995. These roles laid the foundation for his transition into the pharmaceutical industry.
Experience in Drug Safety and Pharmacovigilance
With over 25 years of experience in the pharmaceutical industry, Yong Huang is recognized for his expertise in drug safety evaluation and pharmacovigilance. He has contributed substantially to the field through various leadership roles, ensuring the adherence to regulatory standards and the safety of pharmaceutical products. His work has spanned both academic and industry settings, providing him with a comprehensive understanding of drug safety requirements.
Leadership in Pharmaceutical Industry
Yong Huang's career demonstrates significant leadership within the pharmaceutical industry. His roles at Otsuka, IQVIA, and currently at Bristol-Myers Squibb highlight his capabilities in directing and managing drug safety and pharmacovigilance programs. His extensive experience ensures that pharmaceutical products meet stringent safety and efficacy standards, reflecting his deep understanding of regulatory compliance and drug safety protocols.